Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Pros & Cons of Combining Different Specialties Under One Roof

Gregory C. Gardner, MD, FACP  |  Issue: July 2018  |  July 19, 2018

At one time, I was the principle rheuma­tologist in three of our four combined clinics at our institution, and the knowledge, skills and relationships I acquired have been invaluable to my ability to better care for my patients. It opened a whole new world to me as I learned about such things as Borg scales, interface dermatitis with mucin deposition and the significance of finger-flexor weakness in patients with myositis.

Likewise, since I joined an ILD/rheuma­tology clinic, we have identified a large number of patients with antisynthetase syndrome and ANCA-associated ILD that could have otherwise gone unrecognized, and I have helped evaluate patients with IPAF (interstitial pneumonitis with autoimmune features). We include fellows, residents and occasionally medical students as part of the combined clinics, and the clinics are a favorite experience for many of them. We also have an autoimmune rotation for internal medicine residents, and the combined clinics are an integral part of the month-long rotation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Does It Help Patients?

This MILD (multidisciplinary ILD) conference was attended by specialists in pulmonary ILD, rheumatology, pathology and radiology.

This MILD (multidisciplinary ILD) conference was attended by specialists in pulmonary ILD, rheumatology, pathology and radiology.

Do combined clinics make a difference for patient care? At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) meeting in 2016, Charis Gn, MD, reported on the Brown University experience with combined dermatology/rheumatology.3 She found that 33% of patients left the clinic with a modification or change in diagnosis, and in 20% of the psoriasis patients, a diagnosis of psoriatic arthritis was made or confirmed. Treatment escalation was prescribed for 41% of the psoriasis patients and 79% of the psoriatic arthritis patients.

In a systematic review of the literature regarding combined clinics focused on psoriasis and psoriatic arthritis, Cobo-Ibáñez et al. found the efficacy of therapy improved for patients involved in such clinics and patient satisfaction was higher with the combined experience than with separate visits.4 Overall, 94% of patients surveyed were very satisfied with the combination visits. Data also suggest that having a rheuma­tologist see these patients kept all joint pain from being labeled as psoriatic arthritis because 46% of the patients with psoriasis and joint pain had another cause for their musculoskeletal symptoms.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The down side? The scheduling wait time and the delay in being seen in clinic. Only 41% of patients were seen at their appointment time, which mirrors our experience at the clinics that employ the different-specialists, same-time strategy.

Samycia et al., from the Dermatology and Rheumatology Treatment Clinic in Vancouver, British Columbia, reported on their experience with a dermatology/rheuma­tology clinic.5 They found the combination of specialists proved very helpful for evaluating patients with rash and multiple systemic symptoms. They also found that 51% of lupus patients with rash had a non-lupus cause of the skin problem, such as rosacea, reminding us rheuma­tologists of the importance of Hickam’s dictum—that is, patients can have as many diseases as they darn well please.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:FacilityPractice SupportWorkforce Tagged with:specialty

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease

    September 22, 2021

    Treatment with tocilizimab preserved lung function in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) regardless of a patient’s level of lung involvement, according to a recent study.

    New Africa / shutterstock.com

    A Rheumatologist & Pulmonologist Discuss RA-ILD

    November 14, 2021

    Introduction The understanding and treatment of rheuma­toid arthritis (RA) has evolved dramatically in the past 20 years. As gains have been made in treating joint disease in RA, our understanding of the impact of extra-articular manifestations of RA, such as cardiac and lung disease—specifically interstitial lung disease (ILD)—has gradually increased. While rheumatologists increasingly appreciate the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences